SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

394.8213477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

34.65

90294.05

EPS(TTM)

Face Value()

Div & Yield %

45.29

0.26

Back

GHV Infra Projects standalone net profit rises 138.35% in the June 2026 quarter

Aug 11,2026

Net profit of GHV Infra Projects rose 138.35% to Rs 11.25 crore in the quarter ended June 2026 as against Rs 4.72 crore during the previous quarter ended June 2025. Sales rose 171.69% to Rs 218.60 crore in the quarter ended June 2026 as against Rs 80.46 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	218.60	80.46	172
OPM %	12.71	10.37	-
PBDT	16.02	6.36	152
PBT	15.53	6.32	146
NP	11.25	4.72	138

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)